EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)

Delayed Data
As of Sep 30
 +0.52 / +7.04%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 30.50, with a high estimate of 60.00 and a low estimate of 21.00. The median estimate represents a +285.59% increase from the last price of 7.91.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in EyePoint Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -30.13%
Growthannually -21.92%


Growthquarterly -5.81%
Growthannually 13.98%
Key to the earnings and sales forecast charts.